InvestorsHub Logo

Skiluc

05/17/21 6:54 PM

#48 RE: Skiluc #47

PharmaTher Announces Submission of IND Application with the FDA for Phase 2 Clinical Trial Evaluating Ketamine in the Treatment of Parkinson’s Disease

https://www.otcmarkets.com/stock/PHRRF/news/story?e&id=1868621